Olanzapine reduces craving for alcohol: A DRD4 VNTR polymorphism by pharmacotherapy interaction

Neuropsychopharmacology

Volumn 28, Issue 10, 2003, Pages 1882-1888

  Hutchison, Kent E ^a   Wooden, Angela ^a   Swift, Robert M ^b   Smolen, Andrew ^a   McGeary, John ^a   Adler, Lawrence ^c   Paris, Lyndee ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Alcohol; Craving; DRD4; Gene; Olanzapine

Indexed keywords

ALCOHOL; CYPROHEPTADINE; DOPAMINE 4 RECEPTOR; OLANZAPINE; BENZODIAZEPINE DERIVATIVE; CENTRAL DEPRESSANT AGENT; DOPAMINE 2 RECEPTOR; DRD4 PROTEIN, HUMAN; DRUG DERIVATIVE; PIRENZEPINE; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; DNA POLYMORPHISM; DRUG EFFECT; EUPHORIA; HUMAN; PRIORITY JOURNAL; VARIABLE NUMBER OF TANDEM REPEAT; ADDICTION; ADULT; AFFECT; ASSOCIATION; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; DRUG INTERACTION; FEMALE; GENETIC POLYMORPHISM; GENETICS; INDIVIDUALITY; MALE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AFFECT; ALCOHOL DRINKING; BEHAVIOR, ADDICTIVE; BENZODIAZEPINES; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CHI-SQUARE DISTRIBUTION; CUES; CYPROHEPTADINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; ETHANOL; FEMALE; HUMANS; INDIVIDUALITY; MALE; MINISATELLITE REPEATS; PIRENZEPINE; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0442280345     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300264     Document Type: Article

References (28)

1. Berridge KC, Robinson TE (1998). What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28: 309-369.
2. Bohn MJ, Krahn DD, Staehler BA (1995). Development and initial validation of a measure of drinking urges in abstinent alcoholics. Alcohol Clin Exp Res 19: 600-606.
3. de Wit H (1996). Priming effects with drugs and other reinforcers. Exp Clin Psychopharmacol 4: 5-10.
4. Del Boca FK, Kranzler HR, Brown J, Korner PF (1996). Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. Alcohol Clin Exp Res 20: 1412-1417.
5. Ding Y-C, Chi H-C, Grady DL, Morishima A, Kidd JR, Kidd KK et al (2002). Evidence of positive selection acting at the human dopamine receptor D4 gene locus. Proc Natl Acad Sci 99: 309-314.
6. Drake RE, Xie H, McHugo GJ, Green AI (2000). The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophr Bull 26: 441-449.
7. Gordis E (2000). Contributions of behavioral science to alcohol research: understanding who is at risk and why [In Process Citation]. Exp Clin Psychopharmacol 8: 264-270.
8. Green AI, Zimmet SV, Strous RD, Schildkraut JJ (1999). Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? Harvard Rev Psychiatry 6: 287-296.
9. Hutchison KE, LaChance H, Niaura R, Bryan AD, Smolen A (2002a). The DRD4 VNTR poylmorphism influences reactivity to smoking cues. J Abnorm Psychol 111: 134-143.
10. Hutchison KE, McGeary J, Smolen A, Bryan AD, Swift RM (2002b). The DRD4 VNTR polymorphism moderates craving after alcohol consumption. Health Psychol 21: 139-146.
11. Hutchison KE, McGeary J, Smolen A, Wooden A (2001). Craving after alcohol consumption: olanzapine and the DRD4 VNTR polymorphism. Alcoholism: Clin Exp Res 25: 66a.
12. Hutchison KE, Stallings M, McGeary J, Bryan A. Population stratification in the candidate gene study: fatal threat or red herring? Psychol Bull (in press).
13. Johnson BA, Roache JD, Ait-Daoud N, Zanca NA, Velazquez M (2002). Ondansetron reduces the craving of biologically predisposed alcoholics. Psychopharmacology (Berl) 160: 408-413.
14. Kapur S, Zipursky RB, Jones C, Wilson AA, DaSilva JD, Houle S (1997). Cyproheptadine: a potent in vivo serotonin antagonist [letter]. Am J Psychiatry 154: 884.
15. Lench N, Stanier P, Williamson R (1988). Simple non-invasive method to obtain DNA for gene analysis. Lancet 1: 1356-1358.
16. Lichter JB, Barr CL, Kennedy JL, Van Tol HH, Kidd KK, Livak KJ (1993). A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet 2: 767-773.
17. Martin CS, Earleywine M, Musty RE, Perrine MW, Clinic PU, Swift RM (1993). Development and validation of the Biphasic Alcohol Effects Scale. Alcoholism: Clin Exp Res 17: 140-146.
18. Modell JG, Mountz JM (1995). Focal cerebral blood flow change during craving for alcohol measured by SPECT. J Neuropsychiatry Clin Neurosci 7: 15-22.
19. Modell JG, Mountz JM, Glaser FB, Lee JY (1993). Effect of haloperidol on measures of craving and impaired control in alcoholic subjects. Alcohol Clin Exp Res 17: 234-240.
20. Robinson TE, Berridge KC (1993). The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18: 247-291.
21. Sander T, Harms H, Dufeu P, Kuhn S, Rommelspacher H, Schmidt LG (1997). Dopamine D4 receptor exon III alleles and variation of novelty seeking in alcoholics. Am J Med Genet 74: 483-487.
22. Skinner HA, Allen BA (1982). Alcohol dependence syndrome: measurement and validation. J Abnorm Psychol 91: 199-209.
23. Sobell LC, Sobell MB (1980). Convergent validity: an approach to increasing confidence in treatment outcome conclusions with alcohol and drug abusers. In: Sobell LC, Sobell MB, Ward E (eds) Evaluating Alcohol and Drug Abuse Treatment Effectiveness: Recent Advances pp 177-183, Pergamon Press: New York.
24. Swift RM (1999). Medications and alcohol craving. Alcohol Res Health 23: 207-213.
25. Swift RM, Whelihan W, Kuznetsov O, Buongiorno G, Hsuing H (1994). Naltrexone-induced alterations in human ethanol intoxication. Am J Psychiatry 151: 1463-1467.
26. Wacholder S, Rothman N, Caporaso N (2000). Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst 92: 1151-1158.
27. Watson PE (1989). Total body water and blood alcohol levels: updating the fundamentals. In: Crow KE, Batt RD (ed) Human Metabolism of Alcohol pp 41-56, CRC Press: Boca Raton, FL.
28. Wise RA (1988). The neurobiology of craving: implications for the understanding and treatment of addiction. J Abnorm Psychol 97: 118-132.